Overview
Anna Fioravanti practices practicing medicine in Pisa, Italy.
Her clinical expertise encompasses Anaplastic Thyroid Cancer, Colorectal Cancer, and Thyroid Cancer.
She is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anna Fioravanti
Is Anna Fioravanti a top-rated expert for Anaplastic Thyroid Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Anna Fioravanti is classified as an Experienced expert for Anaplastic Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anna Fioravanti participate in research or clinical trials?
Yes. Anna Fioravanti has published 22 articles and abstracts on conditions like Anaplastic Thyroid Cancer. You can view a list of Anna Fioravanti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anaplastic Thyroid CancerMs. Fioravanti isExperienced. Learn about Anaplastic Thyroid Cancer.
- Colorectal CancerMs. Fioravanti isExperienced. Learn about Colorectal Cancer.
- Thyroid CancerMs. Fioravanti isExperienced. Learn about Thyroid Cancer.